| Display title | Johnson & Johnson Kenvue Spinoff |
| Default sort key | Johnson & Johnson Kenvue Spinoff |
| Page length (in bytes) | 8,811 |
| Namespace ID | 0 |
| Page ID | 1595 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | GardenStateBot (talk | contribs) |
| Date of page creation | 03:46, 19 April 2026 |
| Latest editor | GardenStateBot (talk | contribs) |
| Date of latest edit | 12:17, 12 May 2026 |
| Total number of edits | 2 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 2 |
| Recent number of distinct authors | 1 |
| Transcluded template (1) | Template used on this page:
|
Description | Content |
Page title: (title)
This attribute controls the content of the <title> element. | Johnson & Johnson Kenvue Spinoff |
Article description: (description)
This attribute controls the content of the description and og:description elements. | The 2023 separation of Johnson & Johnson's consumer health division into independent Kenvue Inc., headquartered in New Jersey and including brands like Tylenol and Neutrogena. |
Article type: (type) | Article |
